A comparative study of insulin's pricing policy in the USA and the UK
Συγκριτική ανάλυση της πολιτικής κοστολόγησης της ινσουλίνης στις ΗΠΑ και το Ηνωμένο Βασίλειο
View/
Keywords
Ινσουλίνη ; Πολιτική φαρμάκου ; Φαρμακευτική πολιτική ; ΗΠΑ ; Ηνωμένο Βασίλειο ; ΔιαβήτηςAbstract
The paper at hand analyses the pricing policy of insulin in the USA and the United
Kingdom, as well as the factors that shape it. It was also deemed meaningful to delve
into the epidemiological profile of diabetes in the countries under investigation, in
order to draw conclusions for the policy of each country. The main goal of the paper
is to find the deeper causes of the pricing policy of insulin in the USA and the UK.
Apart from that, another important aspect of analysis are the repercussions or
consequences that a sufficient or insufficient policy may bear, in order to highlight its
importance for the society’s prosperity. Through the analysis, we concluded that it is a
wide range of historical, political, and economic factors that affects the
pharmaceutical pricing policy in each country.
Postgraduate Studies Programme
Οικονομικά και Διοίκηση της ΥγείαςDepartment
Σχολή Οικονομικών, Επιχειρηματικών και Διεθνών Σπουδών. Τμήμα Οικονομικής ΕπιστήμηςNumber of pages
72Language
EnglishCollections
Except where otherwise noted, this item's license is described as
Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ελλάδα
Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ελλάδα